COMMUNIQUÉS West-GlobeNewswire

Novartis Cosentyx® first to show efficacy in all key manifestations of psoriatic arthritis
12/06/2019
First-of-its-kind data shows efficacy and safety of a biologic in the management of axial manifestations of psoriatic arthritis (PsA), which affect up to an estimated 35 million people worldwide[1] 66.3% of patients [...]
Biogen to Present New Safety and Efficacy Data on Biosimilars and Estimates 1.8 Billion Euros in Savings for the European Healthcare System in 2019
12/06/2019
Data to be presented at the European Congress of Rheumatology (EULAR) 2019 highlight real-world evidence confirming the safety and efficacy of anti-TNF biosimilars and high adherence of patients to treatment Biogen’s [...]
Voyager Therapeutics to Present at the Raymond James Life Sciences & MedTech Conference
11/06/2019
CAMBRIDGE, Mass., June 11, 2019 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases, today [...]
Silk Road Medical to Present at the BMO Capital Markets 2019 Prescriptions for Success Healthcare Conference
11/06/2019
SUNNYVALE, Calif., June 11, 2019 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will be participating [...]
Principia Biopharma Appoints Patrick Machado to Board of Directors
11/06/2019
SOUTH SAN FRANCISCO, Calif., June 11, 2019 (GLOBE NEWSWIRE) -- Principia Biopharma Inc. (Nasdaq: PRNB), a late-stage biopharmaceutical company dedicated to bringing transformative oral therapies to patients with [...]
TransMedics Reports First Quarter 2019 Financial Results
11/06/2019
ANDOVER, Mass., June 11, 2019 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, [...]
Nuvectra Files Regulatory Submission with FDA for Algovita® Full-Body MR-Conditional Approval
11/06/2019
PLANO, Texas, June 11, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that it has filed its regulatory submission with the U.S. Food and Drug [...]
Imagin Medical Reports Fiscal 2019 Second Quarter Results
11/06/2019
VANCOUVER, British Columbia and BOSTON, June 11, 2019 (GLOBE NEWSWIRE) -- Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today reported financial results [...]
Axovant Announces Financial Results and Corporate Updates for Fourth Quarter and Fiscal Year Ended March 31, 2019
11/06/2019
Established diversified pipeline of three clinical-stage gene therapy programs for serious neurological disorders including Parkinson’s disease, GM1 gangliosidosis, and Tay-Sachs SUNRISE-PD Phase 2 trial of AXO-Lenti-PD [...]
Oral semaglutide demonstrated cardiovascular safety in people with type 2 diabetes and established cardiovascular disease or high cardiovascular risk in PIONEER 6 trial
11/06/2019
San Francisco, US, 11 June 2019 - Novo Nordisk today announced that the PIONEER 6 trial achieved its primary endpoint by demonstrating non-inferiority of major adverse cardiovascular events (MACE) with oral semaglutide [...]
Vital® Partners With Baptist Health to Deliver Complete Vitrea® Enterprise Imaging Solution
11/06/2019
MINNETONKA, Minn., June 11, 2019 (GLOBE NEWSWIRE) -- Vital announced today continued success with Baptist Health in the implementation of the Vitrea Enterprise Imaging solution. Baptist Health is Arkansas’ largest [...]
La société XBiotech ajoutée à l'indice Russell 3000®
11/06/2019
AUSTIN, Texas, 11 juin 2019 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ : XBIT) a annoncé aujourd'hui que la société avait été ajoutée à la liste préliminaire de l'indice boursier élargi Russell 3000 ® qui prendra effet [...]
Cerecor Set to Join Russell 3000® Index
11/06/2019
ROCKVILLE, Md., June 11, 2019 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for rare and orphan diseases in [...]
DEINOVE & AVRIL completing the development of a natural feed additive
11/06/2019
The tests aimed at validating the dosage required have confirmed a very good efficacy of the ingredient The teams are working to develop a formulation that meets regulatory and industrial requirements for bringing a [...]
Ossur Hf : Transactions in relation to share buyback program
11/06/2019
Announcement no. 36/2019 11 June 2019 Transactions in relation to share buyback program On 14 May 2019, Össur hf. initiated a share buy-back program, see Company announcement no. 31/2019. The purpose of the share [...]
VALNEVA fera un point sur l’avancée de ses programmes de vaccins Lyme et chikungunya le 9 juillet à New York lors d’une journée investisseurs consacrée à la R&D
11/06/2019
Valneva fera un point sur l’avancée de ses programmes de vaccins Lyme et chikungunya le 9 juillet à New York lors d’une journée investisseurs consacrée à la R&D Conférence retransmise en direct à partir de 8.30am [...]
Valneva to Present Lyme Disease and Chikungunya Vaccine Updates at R&D Investor Day in New York City on July 9th
11/06/2019
Valneva to Present Lyme Disease and Chikungunya Vaccine Updates at R&D Investor Day in New York City on July 9 th Live webcast beginning at 8:30am EDT / 2:30pm CEST Saint Herblain (France), June 11, 2019 – Valneva [...]
Eurobio Scientific and Vivo Medical Group enter into exclusive negotiations for the acquisition of two companies in the United Kingdom
11/06/2019
Eurobio Scientific and Vivo Medical Group enter into exclusive negotiations for the acquisition of two companies in the United Kingdom Paris, June 11, 2019 – 5:45 pm Eurobio Scientific enters into exclusive negotiations [...]
Eurobio Scientific et Vivo Medical Group entrent en négociation exclusive pour l’acquisition de deux sociétés au Royaume-Uni
11/06/2019
Eurobio Scientific et Vivo Medical Group entrent en négociation exclusive pour l’acquisition de deux sociétés au Royaume-Uni Paris, le 11 juin 2019 – 17h45 Eurobio Scientific (FR0013240934, ALERS, éligible PEA-PME), [...]

Pages